Post-chemo RPLND — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

ModerateUrological CancersPost-chemo RPLNDSCE Medical Oncology

A 55-year-old man with NSGCT has completed BEP with normalised markers but a 4 cm residual retroperitoneal mass. What next?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Post-chemotherapy RPLND

Post-chemo NSGCT residuals >1 cm: ~40-50% necrosis, ~35-40% teratoma (chemo-resistant), ~10-15% viable GCT. RPLND required. PET-CT has limited utility in NSGCT residuals.

Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cancer